Illumina Ventures — 2017 Investments
3 investments dated 2017 · listed companies and verified rows first · show all
DNA Script develops enzymatic DNA synthesis technology, producing nucleic acids for research and biotech applications.
BiotechDeep TechHardwareParis, FR
Thomas Ybert(Founder)inXavier Godronin
Co-investorsCatalio Capital Management, LPCoatue ManagementKurma PartnersM VenturesSofinnova PartnersCasdin Capital
Developer of microfluidic cell sorting technologies for the biotech industry.
BiotechHardwareMedical DevicesSan Diego, US
Jose Morachis(Executive Officer, Director)inNate Heintzman(Executive Officer, Director)inWilliam Alaynick(Executive Officer, Director)Chris Neary(CEO)in
BoardKenneth Hood(Director)
Co-investorsVertical Venture PartnersWarburg PincusAnzu PartnersFusionX VenturesHemisphere Ventures LLCPaladin Capital Group
BiotechGoleta, US
Patrick Daugherty(Executive Officer, Director)Kristin Loomis(Director)Bill Welch(Director)inNick Naclerio(Director)inJohn Shon(Executive Officer)
Co-investorsIllumina Innovation
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
















